US Stock MarketDetailed Quotes

SABS SAB Biotherapeutics

Watchlist
  • 2.9200
  • -0.0300-1.02%
Close Nov 29 13:00 ET
  • 2.9200
  • 0.00000.00%
Post 17:01 ET
26.95MMarket Cap-463P/E (TTM)

SAB Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
112.47%11.31M
57.52%10.2M
53.89%11.39M
31.67%38.08M
140.12%18.87M
-31.82%5.32M
-1.01%6.48M
10.36%7.4M
115.91%28.92M
7.02%7.86M
Selling and administrative expenses
35.33%3.48M
25.61%3.64M
21.52%4.19M
45.27%23.8M
416.22%14.88M
-36.44%2.57M
-32.70%2.9M
-33.53%3.45M
-4.11%16.38M
-62.82%2.88M
-General and administrative expense
35.33%3.48M
25.61%3.64M
21.52%4.19M
45.27%23.8M
416.22%14.88M
-36.44%2.57M
-32.70%2.9M
-33.53%3.45M
-4.11%16.38M
-62.82%2.88M
Research and development costs
94.81%7.83M
86.29%6.82M
79.60%8.15M
-54.68%16.52M
-39.80%4.3M
-45.33%4.02M
-57.34%3.66M
-65.96%4.54M
-36.28%36.44M
-32.96%7.14M
Other operating expenses
----
-207.70%-263.14K
-62.55%-944.58K
90.63%-2.24M
85.88%-305.01K
64.69%-1.27M
98.65%-85.52K
95.08%-581.1K
60.73%-23.9M
80.46%-2.16M
Operating profit
-112.47%-11.31M
-57.52%-10.2M
-53.89%-11.39M
-31.67%-38.08M
-140.12%-18.87M
31.82%-5.32M
1.01%-6.48M
-245.26%-7.4M
-115.91%-28.92M
-7.02%-7.86M
Net non-operating interest income expense
459.87%199.14K
701.98%281.44K
1,325.46%421.52K
216.99%269.68K
803.08%406.17K
-3.93%-55.34K
15.63%-46.75K
46.33%-34.4K
15.05%-230.51K
-0.07%-57.77K
Non-operating interest income
1,829.64%277.17K
1,211.11%374.56K
758.61%497.89K
723.06%584.97K
1,517.31%484.05K
-17.38%14.36K
80.54%28.57K
630.97%57.99K
207.47%71.07K
250.29%29.93K
Non-operating interest expense
11.96%78.04K
23.63%93.12K
-17.33%76.37K
4.54%315.28K
-11.20%77.88K
-1.31%69.7K
5.73%75.32K
28.27%92.39K
2.42%301.58K
32.33%87.7K
Other net income (expense)
175.72%760.82K
822.99%2.58M
7,096.56%5.94M
-142.06%-4.39M
-6,478.39%-4.39M
-64.83%275.94K
-120.66%-357.52K
-98.95%82.59K
399.80%10.43M
101.66%68.81K
Gain on sale of security
-96.55%6.17K
720.10%2.22M
6,521.24%5.47M
-146.38%-4.82M
-13,020.42%-4.73M
-77.17%178.76K
-120.66%-357.52K
-98.95%82.59K
350.52%10.4M
--36.59K
Other non- operating income (expenses)
676.52%754.65K
--367.83K
--475.13K
1,189.00%435.09K
948.52%337.91K
6,264.31%97.18K
----
----
515.05%33.75K
1,999.48%32.23K
Income before tax
-102.84%-10.35M
-6.61%-7.34M
31.66%-5.03M
-125.45%-42.19M
-191.21%-22.86M
27.89%-5.1M
-41.34%-6.88M
-782.08%-7.35M
-9.16%-18.72M
32.05%-7.85M
Income tax
0
25.63K
Net income
-102.84%-10.35M
-6.61%-7.34M
31.66%-5.03M
-125.14%-42.19M
-190.26%-22.86M
27.89%-5.1M
-44.07%-6.88M
-845.93%-7.35M
-9.31%-18.74M
31.83%-7.87M
Net income continuous Operations
-102.84%-10.35M
-6.61%-7.34M
31.66%-5.03M
-125.14%-42.19M
-190.26%-22.86M
27.89%-5.1M
-44.07%-6.88M
-845.93%-7.35M
-9.31%-18.74M
31.83%-7.87M
Minority interest income
Net income attributable to the parent company
-102.84%-10.35M
-6.61%-7.34M
31.66%-5.03M
-125.14%-42.19M
-190.26%-22.86M
27.89%-5.1M
-44.07%-6.88M
-845.93%-7.35M
-9.31%-18.74M
31.83%-7.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-102.84%-10.35M
-6.61%-7.34M
31.66%-5.03M
-125.14%-42.19M
-190.26%-22.86M
27.89%-5.1M
-44.07%-6.88M
-845.93%-7.35M
-9.31%-18.74M
31.83%-7.87M
Basic earnings per share
-15.46%-1.12
41.91%-0.79
63.01%-0.54
-77.26%-7.64
-112.71%-3.85
39.38%-0.97
-23.64%-1.36
-830.00%-1.46
31.59%-4.31
31.86%-1.81
Diluted earnings per share
-15.46%-1.12
41.91%-0.79
63.01%-0.54
-77.26%-7.64
-112.71%-3.85
39.38%-0.97
-23.64%-1.36
-830.00%-1.46
31.59%-4.31
31.86%-1.81
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Total revenue 0 0 0 0 0 0 0 0 0 0
Operating revenue --0 --0 --0 --0 --0 --0 --0 --0 --0 --0
Cost of revenue
Gross profit
Operating expense 112.47%11.31M 57.52%10.2M 53.89%11.39M 31.67%38.08M 140.12%18.87M -31.82%5.32M -1.01%6.48M 10.36%7.4M 115.91%28.92M 7.02%7.86M
Selling and administrative expenses 35.33%3.48M 25.61%3.64M 21.52%4.19M 45.27%23.8M 416.22%14.88M -36.44%2.57M -32.70%2.9M -33.53%3.45M -4.11%16.38M -62.82%2.88M
-General and administrative expense 35.33%3.48M 25.61%3.64M 21.52%4.19M 45.27%23.8M 416.22%14.88M -36.44%2.57M -32.70%2.9M -33.53%3.45M -4.11%16.38M -62.82%2.88M
Research and development costs 94.81%7.83M 86.29%6.82M 79.60%8.15M -54.68%16.52M -39.80%4.3M -45.33%4.02M -57.34%3.66M -65.96%4.54M -36.28%36.44M -32.96%7.14M
Other operating expenses ---- -207.70%-263.14K -62.55%-944.58K 90.63%-2.24M 85.88%-305.01K 64.69%-1.27M 98.65%-85.52K 95.08%-581.1K 60.73%-23.9M 80.46%-2.16M
Operating profit -112.47%-11.31M -57.52%-10.2M -53.89%-11.39M -31.67%-38.08M -140.12%-18.87M 31.82%-5.32M 1.01%-6.48M -245.26%-7.4M -115.91%-28.92M -7.02%-7.86M
Net non-operating interest income expense 459.87%199.14K 701.98%281.44K 1,325.46%421.52K 216.99%269.68K 803.08%406.17K -3.93%-55.34K 15.63%-46.75K 46.33%-34.4K 15.05%-230.51K -0.07%-57.77K
Non-operating interest income 1,829.64%277.17K 1,211.11%374.56K 758.61%497.89K 723.06%584.97K 1,517.31%484.05K -17.38%14.36K 80.54%28.57K 630.97%57.99K 207.47%71.07K 250.29%29.93K
Non-operating interest expense 11.96%78.04K 23.63%93.12K -17.33%76.37K 4.54%315.28K -11.20%77.88K -1.31%69.7K 5.73%75.32K 28.27%92.39K 2.42%301.58K 32.33%87.7K
Other net income (expense) 175.72%760.82K 822.99%2.58M 7,096.56%5.94M -142.06%-4.39M -6,478.39%-4.39M -64.83%275.94K -120.66%-357.52K -98.95%82.59K 399.80%10.43M 101.66%68.81K
Gain on sale of security -96.55%6.17K 720.10%2.22M 6,521.24%5.47M -146.38%-4.82M -13,020.42%-4.73M -77.17%178.76K -120.66%-357.52K -98.95%82.59K 350.52%10.4M --36.59K
Other non- operating income (expenses) 676.52%754.65K --367.83K --475.13K 1,189.00%435.09K 948.52%337.91K 6,264.31%97.18K ---- ---- 515.05%33.75K 1,999.48%32.23K
Income before tax -102.84%-10.35M -6.61%-7.34M 31.66%-5.03M -125.45%-42.19M -191.21%-22.86M 27.89%-5.1M -41.34%-6.88M -782.08%-7.35M -9.16%-18.72M 32.05%-7.85M
Income tax 0 25.63K
Net income -102.84%-10.35M -6.61%-7.34M 31.66%-5.03M -125.14%-42.19M -190.26%-22.86M 27.89%-5.1M -44.07%-6.88M -845.93%-7.35M -9.31%-18.74M 31.83%-7.87M
Net income continuous Operations -102.84%-10.35M -6.61%-7.34M 31.66%-5.03M -125.14%-42.19M -190.26%-22.86M 27.89%-5.1M -44.07%-6.88M -845.93%-7.35M -9.31%-18.74M 31.83%-7.87M
Minority interest income
Net income attributable to the parent company -102.84%-10.35M -6.61%-7.34M 31.66%-5.03M -125.14%-42.19M -190.26%-22.86M 27.89%-5.1M -44.07%-6.88M -845.93%-7.35M -9.31%-18.74M 31.83%-7.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -102.84%-10.35M -6.61%-7.34M 31.66%-5.03M -125.14%-42.19M -190.26%-22.86M 27.89%-5.1M -44.07%-6.88M -845.93%-7.35M -9.31%-18.74M 31.83%-7.87M
Basic earnings per share -15.46%-1.12 41.91%-0.79 63.01%-0.54 -77.26%-7.64 -112.71%-3.85 39.38%-0.97 -23.64%-1.36 -830.00%-1.46 31.59%-4.31 31.86%-1.81
Diluted earnings per share -15.46%-1.12 41.91%-0.79 63.01%-0.54 -77.26%-7.64 -112.71%-3.85 39.38%-0.97 -23.64%-1.36 -830.00%-1.46 31.59%-4.31 31.86%-1.81
Dividend per share
Currency Unit USD USD USD USD USD USD USD USD USD USD
Audit Opinions -- -- -- Unqualified Opinion -- -- -- -- Unqualified Opinion with Explanatory Notes --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data